You’ve been outdoors—maybe hiking, gardening, or playing with your kids—and now you're feeling off. Fatigue, joint aches, perhaps even a strange rash. Could it be Lyme disease? You’re not alone in wondering.
Lyme disease (Lyme borreliosis), is the most commonly transmitted tick-borne infection in the United States and among the most frequently diagnosed tick-borne infections worldwide. This guide breaks down Lyme disease testing: when to do it, how it works, and how to understand the results.
[signup]
What Is a Lyme Disease Test?
Before discussing when to test or which test to choose, it’s important to understand what a Lyme disease test is and what it’s actually looking for.
Definition and Testing Purpose
Lyme disease is a tick-borne illness caused by the Borrelia burgdorferi bacteria. It is transmitted through the bite of infected ticks and can affect the skin, joints, nervous system, and heart. Early treatment helps prevent serious complications, but testing can be tricky, especially if symptoms are delayed or vague.
A Lyme disease test looks for signs that your immune system has responded to infection with Borrelia burgdorferi, the bacteria that causes Lyme disease. The most common tests detect antibodies—proteins your body produces to fight off the bacteria.
In certain situations—particularly when someone has neurological symptoms such as facial paralysis, memory issues, or unexplained tingling—a provider may order a spinal tap to check for Borrelia DNA or antibodies in the cerebrospinal fluid. This can help diagnose cases where the bacteria have affected the brain or spinal cord, known as neuroborreliosis.
Why Testing Matters
Testing is essential in guiding diagnosis and treatment—especially when symptoms are nonspecific and overlap with other illnesses. A reliable test result can help confirm that Lyme disease is the cause of symptoms, support decisions about antibiotic therapy, and rule out other conditions such as viral infections, autoimmune disorders, or fibromyalgia.
The timing of testing is critical:
- If the test is done too early—within the first few days of infection—your body may not have produced enough antibodies to be detected. This can result in a false negative, where the test says you’re not infected when you actually are.
- On the other hand, if you test months or even years after infection, your body may still show a positive result, even though the bacteria are no longer active. This is because antibodies can persist in the bloodstream long after the infection has been treated successfully.
In addition, not all people with Lyme disease produce measurable antibodies, and some tests may react to other conditions, leading to false positives. That’s why a healthcare provider should always interpret test results alongside your symptoms, physical exam findings, and history of potential tick exposure.
Types of Lyme Disease Tests
Different tests serve different purposes, from screening for early infection to confirming long-term complications.
Two-Tier Antibody Testing (Gold Standard)
This two-step approach is the standard testing method recommended by the CDC and FDA.
- First Tier: ELISA (Enzyme-Linked Immunosorbent Assay) - This initial blood test checks for IgM (early) and IgG (later) antibodies. If the result is positive or borderline, a second test is done.
- Second Tier: Western Blot or Second EIA - Confirms antibody presence and can help identify the stage of infection.
Direct Diagnostic Tests
These look for actual bacterial material rather than antibodies.
- Polymerase Chain Reaction (PCR) Testing Detects Borrelia DNA, mainly in cerebrospinal fluid or joint fluid. It is useful when Lyme affects the nervous system or joints.
- Culture and Antigen Detection - Still experimental and not widely used. These methods try to grow or detect parts of the bacteria directly.
At-Home Tests
At-home Lyme disease test kits are available online and at some pharmacies. These kits typically require you to collect a small blood sample through a finger prick, which you then mail to a lab for analysis. Some tests look for antibodies, while others claim to detect bacterial DNA.
While at-home testing offers convenience and privacy, it comes with limitations. The accuracy and quality of these tests can vary, and not all tests are FDA-reviewed. Some may produce false positives or negatives, especially if used too early or late during illness.
Follow up with a healthcare provider if you receive a positive or unclear result. They can confirm the diagnosis with validated laboratory testing and help determine the appropriate next steps in your care.
When Should You Get Tested?
Timing affects test reliability, and symptoms evolve in stages. Knowing when and why to test can prevent missed or incorrect diagnoses.
Symptom Timeline and Risk Exposure
If you've had symptoms for less than 30 days, antibody levels may be too low to detect.
If you have a bull’s-eye rash (erythema migrans), your doctor may diagnose Lyme disease clinically without a test.
Stages of Lyme Disease and Testing Accuracy
Lyme disease is divided into three stages (early localized, early disseminated, and late). As the disease progresses, test sensitivity improves.
Early Localized Stage (1–4 weeks)
- Patients may have a rash, fever, or fatigue.
- Tests are often negative at this stage, but treatment may still be started based on symptoms.
Early Disseminated Stage (1–4 months)
- Bacteria may spread to the heart, joints, or nervous system.
- Antibodies are more likely to be detected during this stage.
Late Lyme Disease (Months to Years)
- Arthritis or neurologic symptoms may appear.
- Testing is more accurate, but symptoms can resemble other diseases.
Understanding Test Results
Understanding what Lyme disease test results show and when to follow up is key to getting the proper care.
Negative Test Doesn’t Always Mean No Disease
A negative test result may be reassuring but does not definitively exclude Lyme disease.
- If testing is performed too early—typically within the first few weeks of infection—the body may not have produced enough antibodies to be detected. For this reason, false negatives are more common during the early localized stage of the disease.
- If symptoms such as fever, fatigue, or the characteristic erythema migrans (bull’s-eye rash) persist, retesting after 3 to 4 weeks may be appropriate.
Additionally, some individuals may never produce measurable antibodies, a condition called seronegative Lyme disease.
Positive Test Doesn’t Always Mean Active Infection
Antibodies can remain in the bloodstream for months or years after recovery. A positive test may reflect past—not current—illness.
A positive test result indicates that the immune system has responded to the Borrelia burgdorferi bacteria. However, this does not always reflect an active infection. Immunoglobulin G (IgG) antibodies can persist in the bloodstream for many months—or even years—after successful treatment, which may lead to confusion when evaluating lingering symptoms.
To determine the clinical significance of a positive test, healthcare providers must consider the full context, including the patient's symptom profile, potential exposure to ticks, and timing of testing relative to symptom onset.
False Positives and Other Conditions
Lyme disease tests aren’t perfect. In some cases, the immune system may produce antibodies that cross-react with other infections or autoimmune conditions, such as:
- Syphilis
- Epstein-Barr virus (EBV)
- Systemic lupus erythematosus (SLE)
- Rheumatoid arthritis
This cross-reactivity can lead to a false positive result, where the test shows Lyme disease when it’s actually another condition.
Co-Infections and Complications
Ticks that carry Borrelia burgdorferi can also transmit other pathogens. These co-infections can complicate both diagnosis and treatment.
Common Tick-Borne Co-Infections
Ticks can transmit multiple organisms during a single bite. These additional infections may present with overlapping symptoms or may not respond to standard Lyme disease treatment alone.
Common co-infections include:
- Anaplasmosis (Anaplasma phagocytophilum): Causes flu-like symptoms, low white blood cell counts, and elevated liver enzymes.
- Babesiosis (Babesia microti): A parasitic infection of red blood cells, often presenting with fever, chills, and fatigue. Severe cases can resemble malaria.
- Powassan Virus: A rare but serious viral infection that can lead to encephalitis (brain inflammation). Symptoms may include headache, confusion, seizures, and, in some cases, long-term neurological impairment.
- Ehrlichiosis (Ehrlichia chaffeensis): Similar to anaplasmosis but more common in the southeastern and south-central U.S.
- Bartonellosis (Bartonella spp.): Some evidence suggests possible co-transmission, though more research is needed to confirm its role in tick-borne disease.
These co-infections can intensify the clinical presentation and may require different or additional treatments beyond standard Lyme disease protocols.
When to Suspect Co-Infections
Co-infections should be suspected when symptoms are more severe than expected, when symptoms persist despite appropriate Lyme disease treatment, or when the clinical picture includes features not typically associated with Lyme disease alone.
Examples of red flags that may suggest co-infection include:
- High fevers without improvement after initial antibiotic therapy
- Relapsing symptoms following initial recovery
- Symptoms such as hemolytic anemia, confusion, or persistent night sweats
- Poor response to doxycycline, which does not treat certain co-infections like Babesia
Further diagnostic testing and consultation with an infectious disease specialist may be required when co-infection is suspected. Identifying and managing these overlapping infections can significantly improve outcomes and reduce long-term complications.
Limitations and Future Directions
Current tests have limitations—especially in the early stages. No single test can definitively confirm early Lyme disease in all patients.
Researchers are exploring newer tests, including:
- Antigen Detection: Finds actual bacterial proteins rather than antibodies.
- Biomarker-Based Tests: This may help diagnose Lyme earlier and more accurately.
Frequently Asked Questions (FAQs)
Q: Can someone have Lyme disease even if the test is negative?
Yes. In early infection, the immune system may not have produced detectable antibodies yet, which can lead to a false-negative result.
Q: What is the most reliable test for diagnosing Lyme disease?
The CDC-recommended two-tiered testing approach—an initial ELISA test followed by a confirmatory Western Blot or second EIA—is considered the standard for laboratory diagnosis.
Q: How soon after a tick bite should testing be done?
Testing is most accurate at least 2–4 weeks after exposure. If a characteristic rash (erythema migrans) develops, a clinical diagnosis may be made without testing.
Q: Do positive Lyme antibodies mean the infection is still active?
Not always. Antibodies can remain in the bloodstream long after the infection has resolved and do not necessarily indicate ongoing disease.
Q: Are at-home Lyme disease tests reliable?
Some at-home tests are FDA-cleared, but others are not. Results should always be reviewed and confirmed with a licensed healthcare provider.
[signup]
Key Takeaways
- Lyme disease is caused by Borrelia burgdorferi and is primarily diagnosed through antibody testing.
- The two-tiered testing approach (ELISA followed by Western Blot or a second EIA) remains the gold standard the CDC and FDA recommended.
- Test timing is critical. Testing too early can lead to false negatives, and antibodies may take several weeks to become detectable.
- A positive test does not always mean active infection, as antibodies can persist long after treatment.
- Ticks may carry multiple pathogens, such as Anaplasma or Babesia, which can complicate symptoms and diagnosis.
- While at-home Lyme tests may offer convenience, their accuracy varies. A healthcare provider should always confirm results.
- Current testing has limitations in early disease, and research is ongoing to develop more accurate direct detection methods.
%201.svg){kind=logo}
